Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...

A class of diabetes drugs known as SGLT2 inhibitors may significantly reduce the risk of organ rejection in patients ...

Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

Antidiabetic drug classes show varied associations with liver outcomes in T2DM, with SGLT2 inhibitors and GLP-1 RA ranking highest.

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 inhibitors, GLP-1 receptor agonists, and more.